Literature DB >> 3087802

The radioimmunoassay of bovine and human follicular fluid and serum inhibin.

R I McLachlan, D M Robertson, H G Burger, D M de Kretser.   

Abstract

A radioimmunoassay for inhibin in bovine and human follicular fluid (bFF, hFF) and serum from both species was developed based on an antiserum raised in a rabbit to purified bovine 58 kDa inhibin. Following immunization, parallel changes in plasma FSH and inhibin antibody titre were observed suggesting inhibin neutralization in vivo. The antiserum neutralized bFF, hFF and purified 31 kDa and 58 kDa inhibin activity in an in vitro bioassay system. Purified 58 kDa and 31 kDa inhibin were iodinated using a chloramine-T procedure and the 125I-inhibin purified by elution from Matrex Red A, with the iodinated molecules showing similar physicochemical properties to non-iodinated inhibin. Both tracers were stable in bFF but only 125I-31 kDa inhibin was stable in serum. A second antibody RIA system using either tracer yielded a parallel displacement between purified 31 kDa and 58 kDa inhibin. The cross-reaction in the RIA of inhibin from different species when expressed in terms of their bioactivity was bFF 100%, hFF 30%, ovine FF less than 1% and rat ovarian extract non-detectable. Rat LH and FSH, ovine LH and FSH, hCG, bovine TSH, LHRH, ovalbumin and bovine serum albumin showed less than 0.5% cross-reactivity using either tracer. Similar profiles of both bio- and immunoactive inhibin were observed at each stage of the inhibin purification procedure. The in vitro biological to immunological ratios for a number of purified 31 kDa and 58 kDa inhibin preparations using both tracers in the RIA, ranged from 0.30 to 0.43. The RIA was modified for serum by using 125I-31 kDa inhibin as tracer and an elevated temperature (30 degrees C) to minimize non-specific effects. No detectable activity was determined in steer or human post-menopausal serum whilst bull and human female serum showed parallel dose-response curves to their respective follicular fluid standards with circulating levels of 0.9 and 1.1 ng/ml respectively.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3087802     DOI: 10.1016/0303-7207(86)90096-1

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  4 in total

Review 1.  Recent advances in the human physiology of inhibin secretion.

Authors:  D M de Kretser; D M Robertson; G P Risbridger
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

Review 2.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

3.  Identification of biologically active inhibin in the peritoneal fluid of women.

Authors:  R B Billiar; R Hemmings; P Smith; N Groome
Journal:  J Assist Reprod Genet       Date:  1995-01       Impact factor: 3.412

4.  Relative roles of follicle-stimulating hormone and luteinizing hormone in the control of inhibin secretion in normal men.

Authors:  R I McLachlan; A M Matsumoto; H G Burger; D M de Kretser; W J Bremner
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.